1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomib

Technology appraisal guidance [TA427] Published date: 11 January 2017

  • Guidance
  • Tools and resources
  • Information for the public
  • History
  • Share
    • Share
    • Linked In
    • Twitter
    • Facebook
    • Email
    • More...

Tools and resources

Tools to help you put the guidance into practice.

Resource impact

  • Resource impact template 11 January 2017   Excel 1.04 MB
  • Resource impact report 11 January 2017   PDF 332.83 KB

Guidance into practice

  • About the Into practice guide
  • Practical steps to improving the quality of care and services using NICE guidance
NICE
  • About NICE
  • Into practice
  • News
  • Contact us
  • Leave feedback
  • Jobs
  • Newsletters and alerts
  • Blog
  • Twitter
  • YouTube
  •   Facebook
  • LinkedIn

Explore

  • Guidance
  • Pathways
  • Standards and indicators
  • Evidence search
  • BNF
  • BNFC
  • Clinical knowledge summaries
  • Journals and databases

Reusing our content

  • Reuse information
  • NICE UK Open Content Licence

Get involved

  • Register as a stakeholder
  • Citizens council
  • Consultations
  • Fellows and scholars
  • Join a committee
  • Meetings in public
  • Student champions
  • Tenders
  • NICE and the public
  • Accessibility
  • Freedom of information
  • Syndication services
  • Glossary
  • Terms and conditions
  • Privacy notice

© NICE [year]. All rights reserved. Subject to Notice of rights.